EMTING (Tigecycline) 50 mg Injection

EMTING (Tigecycline) 50 mg Injection is a glycylcycline-class antibiotic designed to combat a wide range of bacterial infections, including those resistant to other antibiotics. Tigecycline works by binding to the bacterial ribosome, inhibiting protein synthesis, and thereby stopping bacterial growth.

Indications include:

• Complicated skin and soft tissue infections
• Complicated intra-abdominal infections
• Community-acquired bacterial pneumonia

Due to an observed increase in all-cause mortality in clinical trials, Tigecycline should be reserved for use when alternative treatments are not suitable